fdhggf

Friday, September 28, 2007

News Briefs Pharma

FDA Law web log had a very interesting post Wednesday on FDA's recent letter requesting comment on unconcerned 180-day exclusivity forfeiture and Orange brochure patent delisting issues. Merck oHG, which is Merck KgAA's generic subsidiary.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)